Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, volume I.

Abstract

There is a crucial necessity to identify new pathophysiological pathways and therapeutic targets for neurological and neuropsychiatric diseases, as they are rising as leading causes of death, disability, and overall disease burden (Murray et al., 2012). Bearing in mind the potential role of neuroinflammation and the subsequent oxidative/nitrosative damage in these illnesses (Caldwell et al., 2020) the development of new drugs based in the modulation of the immune response is a necessary approach for future therapeutic interventions that deserves further consideration from the standpoint of the neuropharmacology. Thus, the goal of this Research Topic is to offer a view of the current developments in the neuroimmune pharmacology realm for the neurological and neuropsychiatric diseases. This research topic offers an overview of the neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases through 11 articles written by 80 authors.